Medical solicitation is familiar among most medical professionals, not just CKD patients.
Physicians' incentive for prescription drugs is widespread, seemingly contrary to the ethics rules, and circumvented in sophisticated ways. The doctor receives funding for conferences, trips, gifts, events, etc. In return, doctors aspire to provide the company's prescriptions. Medical campaigning is not outlawed and has no uniform and transparent rules. In cases where drug companies introduce a new drug, the rewards are even more generous! Is there a regulatory failure here? In my opinion, YES. Unfortunately, you will not find (to the best of my knowledge) primary legislation that prohibits this phenomenon.
The next post: A detailed answer concerning kidney cysts. This is a partial quote from a response sent to a CKD patient.
May interest you:
Add New Post